Valor pronóstico de la ruta de EGFR-PI3K-pAKT-mTOR-pS6 en los carcinomas epidermoides nasosinusales

This publication has 27 references indexed in Scilit:

• A comprehensive comparative analysis of treatment modalities for sinonasal malignancies
  Cancer, 2017
• Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances
  Nature Reviews Clinical Oncology, 2014
• PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer
  Clinical Cancer Research, 2013
• Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
  Cancer Discovery, 2013
• Exploiting the Head and Neck Cancer Oncogenome: Widespread PI3K-mTOR Pathway Alterations and Novel Molecular Targets
  Cancer Discovery, 2013
• Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
  Science, 2011
• Gene amplification and protein overexpression of EGFR and ERBB2 in sinonasal squamous cell carcinoma
  Cancer, 2011
• EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy
  Expert Opinion on Therapeutic Targets, 2010
• The PI3K Pathway As Drug Target in Human Cancer
  Journal of Clinical Oncology, 2010
• Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma
  International Journal of Cancer, 2004